Dr. Blanchette is an epidemiologist and health services researcher with expertise in health economics and outcomes research, health data analytics and pharmaceutical use. He is currently the Director of the Data Science Initiative and an Associate Professor of Public Health Sciences with the College of Health & Human Services at the University of North Carolina at Charlotte. He is also Vice President and Practice Leader for the Evidence Strategy, Generation and Communication Practice at Precision Health Economics and holds adjunct positions at the W.G. (Bill) Heffner VA Medical Center, Salisbury, NC as well as with the Department of Pharmaceutical Marketing at the Saint Joseph's University Erivan Haub School of Business. He also holds an adjunct position with Division of Pharmaceutical Outcomes & Policy at the University of North Carolina at Chapel Hill Eshelman School of Pharmacy. He has over a decade of experience in leading and managing health economics and outcomes research programs, teams and departments in the pharmaceutical industry and in management consulting.
Dr. Blanchette is a member of the editorial board for the Journal of Medical Economics and Current Medical Research and Opinion. He has authored over 70 papers in clinical and economic journals and presented over 100 studies at national conferences. He serves in leadership positions for the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) as well as the International Society for Pharmacoepidemiology and Drug Safety (ISPE) and is a peer reviewer for the Agency for Healthcare Research and Quality's (AHRQ) Health Information Technology Research study section and the Patient-Centered Outcomes Research Institute (PCORI).
- Proceedings of the AMCP partnership forum: Enabling the exchange of clinical and economic information pre-FDA approval. Journal of Managed Care and Specialty Pharmacy. 2017 Jan;23(1):105-12.
- Blanchette CM, Zacherle E, Noone J, Van Doren BA, Roy D, Howden R. One-year prevalence, comorbidities and cost of hospitalizations for Alpha-1 Antitrypsin Deficiency among patients with COPD in the US. Journal of Health Economics and Outcomes Research. 2017;5(1):65-74.
- Blanchette CM, Liang C, Lubeck DP, Newsome B, Rossetti S, Gu X, Gutierrez B, Lin ND. Progression of autosomal dominant kidney disease: measurement of the stage transitions of chronic kidney disease. Drugs in Context. 2015; 4: 212275. doi: 10.7573/dic.212275